Sangamo Therapeutics Inc. buy Barclays PLC
Start price
14.05.25
/
50%
€0.41
Target price
14.05.26
€4.47
Performance (%)
-62.54%
End price
15.05.26
-
Summary
This prediction is currently being closed. The BUY prediction by Barclays_PLC for Sangamo Therapeutics Inc. is performing very badly with a performance of -62.54%. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sangamo Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -2.796% | -1.396% | -0.221% |
| iShares Nasdaq 100 | -6.352% | -0.407% | 28.998% |
| iShares Nikkei 225® | -6.943% | -0.275% | 48.214% |
| iShares S&P 500 | -3.410% | 0.396% | 20.281% |
Comments by Barclays_PLC for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Barclays PLC from $9.00 to $5.00. They now have an "overweight" rating on the stock.
Ratings data for SGMO provided by MarketBeat
In the thread Trading Sangamo Bioscienes
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Barclays_PLC for Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.12
14.11.24
14.11.24
€8.52
14.11.25
14.11.25
-81.54%
15.11.25
15.11.25
